The deal, valuing the firm at 46 times its 2020 revenue, is the latest in a rush of digital health companies going public spurred in part by COVID-19.
The deal, valuing the firm at 46 times its 2020 revenue, is the latest in a rush of digital health companies going public spurred in part by COVID-19.
Copyright © 2024 | WordPress Theme by MH Themes